[1] H. Tang, X. Zhao, X. Jiang, Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing, Adv. Drug Deliv. Rev. 168 (2020) 55-78 [2] M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J.A. Doudna, E. Charpentier, A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science 337 (6096) (2012) 816-821 [3] P. Mali, L. Yang, K.M. Esvelt, J. Aach, M. Guell, J.E. DiCarlo, J.E. Norville, G.M. Church, RNA-guided human genome engineering via Cas9, Science 339 (6121) (2013) 823-826 [4] H. Mollanoori, H. Shahraki, Y. Rahmati, S. Teimourian, CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment, Hum. Immunol. 79 (12) (2018) 876-882 [5] H. Mollanoori, S. Teimourian, Therapeutic applications of CRISPR/Cas9 system in gene therapy, Biotechnol. Lett. 40 (6) (2018) 907-914 [6] F.A. Ran, L. Cong, W.X. Yan, D.A. Scott, J.S. Gootenberg, A.J. Kriz, B. Zetsche, O. Shalem, X. Wu, K.S. Makarova, In vivo genome editing using Staphylococcus aureus Cas9, Nature 520 (7546) (2015) 186-191 [7] M. Tabebordbar, K. Zhu, J.K. Cheng, W.L. Chew, J.J. Widrick, W.X. Yan, C. Maesner, E.Y. Wu, R. Xiao, F.A. Ran, In vivo gene editing in dystrophic mouse muscle and muscle stem cells, Science 351 (6271) (2016) 407-411 [8] W. Peng, Z. Lingmin, X. Yangzhouyun, W. Nuoxin, T. Rongbing, Z. Wenfu, J. Xingyu, Genome editing for cancer therapy: delivery of Cas9 protein/sgRNA plasmid via a gold nanocluster/lipid core-shell nanocarrier, Adv. Sci. 4 (11) (2017) 1700175 [9] W. Peng, Z. Lingmin, Z. Wenfu, C. Liman, G. Zhaorong, X. Yangzhouyun, W. Le, T. Rongbing, F. Qiang, H. Yoh, G. Kohsuke, H. Zhijian, W. Xiaochun, J. Xingyu, Thermo-triggered release of CRISPR-Cas9 system by lipid-encapsulated gold nanoparticles for tumor therapy, Angew. Chem. In. Ed. 57 (6) (2018) 1491-1496 [10] J.B. Miller, S. Zhang, P. Kos, H. Xiong, K. Zhou, S.S. Perelman, H. Zhu, D.J. Siegwart, Non-viral CRISPR/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of cas9 mRNA and sgRNA, Angew. Chem. In. Ed. 56 (4) (2017) 1059-1063 [11] T.L. Roth, C. Puig-Saus, R. Yu, E. Shifrut, J. Carnevale, P.J. Li, J. Hiatt, J. Saco, P. Krystofinski, H. Li, V. Tobin, D.N. Nguyen, M.R. Lee, A.L. Putnam, A.L. Ferris, J.W. Chen, J.-N. Schickel, L. Pellerin, D. Carmody, G. Alkorta-Aranburu, D. del Gaudio, H. Matsumoto, M. Morell, Y. Mao, M. Cho, R.M. Quadros, C.B. Gurumurthy, B. Smith, M. Haugwitz, S.H. Hughes, J.S. Weissman, K. Schumann, J.H. Esensten, A.P. May, A. Ashworth, G.M. Kupfer, S.A.W. Greeley, R. Bacchetta, E. Meffre, M.G. Roncarolo, N. Romberg, K.C. Herold, A. Ribas, M.D. Leonetti, A. Marson, Reprogramming human T cell function and specificity with non-viral genome targeting, Nature 559 (2018) 405-409 [12] E.A. Stadtmauer, J.A. Fraietta, M.M. Davis, A.D. Cohen, K.L. Weber, E. Lancaster, P.A. Mangan, I. Kulikovskaya, M. Gupta, F. Chen, L. Tian, V.E. Gonzalez, J. Xu, I.-Y. Jung, J.J. Melenhorst, G. Plesa, J. Shea, T. Matlawski, A. Cervini, A.L. Gaymon, S. Desjardins, A. Lamontagne, J. Salas-Mckee, A. Fesnak, D.L. Siegel, B.L. Levine, J.K. Jadlowsky, R.M. Young, A. Chew, W.-T. Hwang, E.O. Hexner, B.M. Carreno, C.L. Nobles, F.D. Bushman, K.R. Parker, Y. Qi, A.T. Satpathy, H.Y. Chang, Y. Zhao, S.F. Lacey, C.H. June, CRISPR-engineered T cells in patients with refractory cancer, Science 367 (6481) (2020) eaba7365 [13] Z. Wang, W. Liu, H. Xu, X. Yang, Preparation and in vitro studies of stealth PEGylated PLGA nanoparticles as carriers for arsenic trioxide, Chinese J Chem. Eng. 15 (6) (2007) 795-801 [14] X. Li, Q. Feng, X. Jiang, Microfluidic synthesis of Gd-based nanoparticles for fast and ultralong MRI signals in the solid tumor, Adv. Healthc. Mater. 8 (20) (2019) 1900672 [15] J. Sun, L. Zhang, J. Wang, Q. Feng, D. Liu, Q. Yin, D. Xu, Y. Wei, B. Ding, X. Shi, X. Jiang, Tunable rigidity of (polymeric core)-(lipid shell) nanoparticles for regulated cellular uptake, Adv. Mater. 27 (8) (2015) 1402-1407 [16] X. Li, X. Jiang, Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles, Adv. Drug Deliv. Rev. 128 (2018) 101-114 [17] L. Zhang, Q. Feng, J. Wang, S. Zhang, B. Ding, Y. Wei, M. Dong, J.-Y. Ryu, T.-Y. Yoon, X. Shi, J. Sun, X. Jiang, Microfluidic synthesis of hybrid nanoparticles with controlled lipid layers: understanding flexibility-regulated cell-nanoparticle interaction, ACS Nano 9 (10) (2015) 9912-9921 |